Showing results (341-350 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|May 13, 2025
Budget Impact of Shifting the Treatment Setting of Unresectable Liver Metastases Associated with Primary Colorectal Cancer Using Y-90 Resin Microspheres from the Outpatient Hospital to the Office-Based LaboratoryDavid C Sperling, Katrine Wallace, Nanette von Oppen, et al.Clinicoeconomics and Outcomes Research : CEOR|May 7, 2025
Cost-Effectiveness of a Community First Responder System for Out-of-Hospital Cardiac Arrest in PolandJerzy Jaskuła, Goran Medic, Sanjay Verma, et al.Clinicoeconomics and Outcomes Research : CEOR|September 16, 2025
Determinants of Economic Costs Following Road Traffic Injuries in Canada: A Quantile Regression Forests Machine Learning ApproachSomayeh Momenyan, Herbert Chan, Lina Jae, et al.Clinicoeconomics and Outcomes Research : CEOR|July 31, 2014
Oncology drug health technology assessment recommendations: Canadian versus UK experiencesIsabelle Chabot, Angela RocchiClinicoeconomics and Outcomes Research : CEOR|April 24, 2013
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza studyCarlo Lazzaro, Roberto Bordonaro, Francesco Cognetti, et al.Clinicoeconomics and Outcomes Research : CEOR|April 24, 2013
Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy managementSharrel L Pinto, Jinender Kumar, Gautam Partha, et al.Clinicoeconomics and Outcomes Research : CEOR|May 3, 2013
Comparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapyReema Mody, Debra Eisenberg, Likun Hou, et al.Clinicoeconomics and Outcomes Research : CEOR|February 14, 2013
Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictionsDaryl S Spinner, Julie Birt, Jeffrey W Walter, et al.Clinicoeconomics and Outcomes Research : CEOR|February 23, 2013
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United StatesAlok A Khorana, Mehul R Dalal, Jay Lin, et al.Clinicoeconomics and Outcomes Research : CEOR|January 10, 2013
Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) studyLuca Degli Esposti, Guido Didoni, Teresa Simon, et al.Pageof 102